The Biotech Growth Trust PLC (BIOG) - Net Assets

Latest as of September 2025: GBX257.88 Million GBX ≈ $31.38K USD

Based on the latest financial reports, The Biotech Growth Trust PLC (BIOG) has net assets worth GBX257.88 Million GBX (≈ $31.38K USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX289.97 Million ≈ $35.28K USD) and total liabilities (GBX32.10 Million ≈ $3.91K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read The Biotech Growth Trust PLC debt and liabilities for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX257.88 Million
% of Total Assets 88.93%
Annual Growth Rate 9.39%
5-Year Change -63.22%
10-Year Change -41.57%
Growth Volatility 38.11

The Biotech Growth Trust PLC - Net Assets Trend (2004–2025)

This chart illustrates how The Biotech Growth Trust PLC's net assets have evolved over time, based on quarterly financial data. Also explore The Biotech Growth Trust PLC assets under control for the complete picture of this company's asset base.

Annual Net Assets for The Biotech Growth Trust PLC (2004–2025)

The table below shows the annual net assets of The Biotech Growth Trust PLC from 2004 to 2025. For live valuation and market cap data, see market cap of The Biotech Growth Trust PLC.

Year Net Assets Change
2025-03-31 GBX221.21 Million
≈ $26.91K		 -38.78%
2024-03-31 GBX361.31 Million
≈ $43.96K		 +9.39%
2023-03-31 GBX330.29 Million
≈ $40.19K		 -16.21%
2022-03-31 GBX394.21 Million
≈ $47.96K		 -34.46%
2021-03-31 GBX601.47 Million
≈ $73.18K		 +64.53%
2020-03-31 GBX365.57 Million
≈ $44.48K		 -10.59%
2019-03-31 GBX408.88 Million
≈ $49.75K		 -2.04%
2018-03-31 GBX417.40 Million
≈ $50.79K		 -6.92%
2017-03-31 GBX448.41 Million
≈ $54.56K		 +18.45%
2016-03-31 GBX378.57 Million
≈ $46.06K		 -29.01%
2015-03-31 GBX533.30 Million
≈ $64.89K		 +56.74%
2014-03-31 GBX340.25 Million
≈ $41.40K		 +39.19%
2013-03-31 GBX244.44 Million
≈ $29.74K		 +56.56%
2012-03-31 GBX156.13 Million
≈ $19.00K		 +29.23%
2011-03-31 GBX120.82 Million
≈ $14.70K		 +0.33%
2010-03-31 GBX120.42 Million
≈ $14.65K		 +71.51%
2009-03-31 GBX70.21 Million
≈ $8.54K		 +8.85%
2008-03-31 GBX64.50 Million
≈ $7.85K		 -16.02%
2007-03-31 GBX76.80 Million
≈ $9.34K		 +110.10%
2006-03-31 GBX36.56 Million
≈ $4.45K		 +20.06%
2005-03-31 GBX30.45 Million
≈ $3.70K		 -9.42%
2004-03-31 GBX33.62 Million
≈ $4.09K		 --

Equity Component Analysis

This analysis shows how different components contribute to The Biotech Growth Trust PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Common Stock GBX6.78 Million 3.06%
Other Components GBX214.43 Million 96.94%
Total Equity GBX221.21 Million 100.00%

The Biotech Growth Trust PLC Competitors by Market Cap

The table below lists competitors of The Biotech Growth Trust PLC ranked by their market capitalization.

Company Market Cap
Magnetic North Acquisition Corp
V:MNC
 $3.21 Million
Sabio Holdings Inc
V:SBIO
 $3.21 Million
Fidelity Japanese Values PLC ORD
LSE:FJV
 $3.22 Million
Springs Global Participações S.A.
SA:SGPS3
 $3.22 Million
Miramar Resources Ltd
AU:M2R
 $3.21 Million
Appulse Corp
V:APL
 $3.21 Million
NORTHSTAR GOLD CORP.
F:3WV
 $3.21 Million
Millennium Silver Corp
V:MSC
 $3.20 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in The Biotech Growth Trust PLC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 361,307,000 to 221,206,000, a change of -140,101,000 (-38.8%).
  • Net loss of 82,661,000 reduced equity.
  • Share repurchases of 54,483,000 reduced equity.
  • Other comprehensive income decreased equity by 250,417,000.
  • Other factors increased equity by 247,460,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income GBX-82.66 Million -37.37%
Share Repurchases GBX54.48 Million -24.63%
Other Comprehensive Income GBX-250.42 Million -113.21%
Other Changes GBX247.46 Million +111.87%
Total Change GBX- -38.78%

Book Value vs Market Value Analysis

This analysis compares The Biotech Growth Trust PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 180.93x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 1137.13x to 180.93x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-03-31 GBX1.12 GBX1270.00 x
2005-03-31 GBX1.01 GBX1270.00 x
2006-03-31 GBX1.33 GBX1270.00 x
2007-03-31 GBX1.29 GBX1270.00 x
2008-03-31 GBX1.00 GBX1270.00 x
2009-03-31 GBX1.25 GBX1270.00 x
2010-03-31 GBX2.17 GBX1270.00 x
2011-03-31 GBX1.84 GBX1270.00 x
2012-03-31 GBX2.45 GBX1270.00 x
2013-03-31 GBX3.81 GBX1270.00 x
2014-03-31 GBX5.00 GBX1270.00 x
2015-03-31 GBX8.16 GBX1270.00 x
2016-03-31 GBX6.11 GBX1270.00 x
2017-03-31 GBX7.80 GBX1270.00 x
2018-03-31 GBX7.47 GBX1270.00 x
2019-03-31 GBX7.51 GBX1270.00 x
2020-03-31 GBX8.10 GBX1270.00 x
2021-03-31 GBX15.02 GBX1270.00 x
2022-03-31 GBX9.51 GBX1270.00 x
2023-03-31 GBX8.20 GBX1270.00 x
2024-03-31 GBX10.02 GBX1270.00 x
2025-03-31 GBX7.02 GBX1270.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently The Biotech Growth Trust PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -37.37%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: -0.34x
  • • Equity Multiplier: 1.02x
  • Recent ROE (-37.37%) is below the historical average (7.78%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 41.69% 93.64% 0.44x 1.01x GBX10.65 Million
2005 -10.06% 0.00% -0.07x 1.01x GBX-6.11 Million
2006 22.66% 85.60% 0.25x 1.07x GBX4.63 Million
2007 0.91% 22.29% 0.04x 1.05x GBX-6.98 Million
2008 -13.84% 0.00% -0.14x 1.03x GBX-15.38 Million
2009 25.60% 92.93% 0.26x 1.06x GBX10.96 Million
2010 23.82% 94.10% 0.23x 1.10x GBX16.65 Million
2011 1.66% 63.25% 0.02x 1.12x GBX-10.08 Million
2012 25.95% 91.71% 0.27x 1.04x GBX24.91 Million
2013 31.78% 99.19% 0.29x 1.11x GBX52.19 Million
2014 25.37% 98.90% 0.23x 1.12x GBX52.31 Million
2015 40.18% 99.60% 0.37x 1.10x GBX160.93 Million
2016 -34.06% 0.00% -0.30x 1.12x GBX-166.81 Million
2017 21.98% 97.84% 0.22x 1.03x GBX53.58 Million
2018 -7.13% 0.00% -0.06x 1.07x GBX-71.52 Million
2019 5.16% 91.56% 0.05x 1.05x GBX-19.79 Million
2020 16.66% 95.32% 0.16x 1.10x GBX24.34 Million
2021 33.32% 98.08% 0.31x 1.08x GBX140.28 Million
2022 -51.35% 0.00% -0.49x 1.08x GBX-241.84 Million
2023 -12.50% 0.00% -0.10x 1.09x GBX-74.33 Million
2024 20.65% 92.85% 0.20x 1.14x GBX38.47 Million
2025 -37.37% 0.00% -0.34x 1.02x GBX-104.78 Million

Industry Comparison

This section compares The Biotech Growth Trust PLC's net assets metrics with peer companies in the Asset Management industry.

Industry Context

  • Industry: Asset Management
  • Average net assets among peers: $745,852,800
  • Average return on equity (ROE) among peers: 2.99%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
The Biotech Growth Trust PLC (BIOG) GBX257.88 Million 41.69% 0.12x $3.21 Million
3I Infrastructure PLC (3IN) $1.20 Billion 4.98% 0.15x $42.14 Million
Albion Enterprise VCT PLC (AAEV) $61.87 Million 11.55% 0.03x $3.29 Million
abrdn Asian Income Fund Limited (AAIF) $431.87 Million 14.17% 0.08x $5.17 Million
Abrdn Asia Focus PLC (AAS) $98.67 Million 9.82% 0.09x $7.49 Million
Albion Technology & General VCT PLC (AATG) $64.83 Million 5.63% 0.01x $3.22 Million
Abrdn PLC (ABDN) $4.56 Billion 10.22% 39.48x $45.21 Million
Aberdeen Diversified Income and Growth Trust PLC (ADIG) $426.87 Million 6.29% 0.20x $450.86K
Aquila Energy Efficiency Trust PLC (AEET) $69.67 Million -2.91% 0.02x $261.59K
Aquila European Renewables Income PLC (AERI) $372.54 Million -8.03% 0.00x $79.35 Million
Artemis UK Future Leaders plc (AFL) $174.91 Million -21.80% 0.02x $415.29

About The Biotech Growth Trust PLC

LSE:BIOG UK Asset Management
Market Cap
$3.21 Million
GBX26.35 Billion GBX
Market Cap Rank
#29110 Global
#568 in UK
Share Price
GBX1270.00
Change (1 day)
-0.31%
52-Week Range
GBX686.00 - GBX1342.00
All Time High
GBX1736.00
Categories
Companies in UK Asset Management Banking & Financial
About

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create … Read more